# OnCo record gemcitabine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/gemcitabine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "gemcitabine" ;
  schema:name "Gemcitabine"@en ;
  schema:description "A versatile chemotherapy used in pancreatic, bladder, lung, ovarian, breast and biliary cancers, in nasopharyngeal cancer, and as a bladder instillation."@en ;
  schema:url <https://onco.cc/drugs/gemcitabine/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Gemcitabine> ;
  owl:sameAs <http://www.wikidata.org/entity/Q414143> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=gemcitabine>, <https://www.nice.org.uk/guidance/ta25>, <https://www.nice.org.uk/guidance/ng85/chapter/Recommendations> ;
  onco:status "approved" ;
  onco:tag "gap-fill", "generic", "who-essential" ;
  onco:modality "Nucleoside analogue (deoxycytidine)" ;
  schema:alternateName "Gemzar / Infugem" ;
  onco:approval "US 1996: Pancreatic cancer", "US 1998: NSCLC with cisplatin", "US 2004: Metastatic breast cancer with paclitaxel", "US 2006: Ovarian cancer with carboplatin", "UK 2001: Pancreatic cancer: NICE TA25 (8 May 2001), since replaced by the NG85 guideline, which recommends gemcitabine alone for people not well enough for combination chemotherapy (1.9.6) and as adjuvant treatment for those who cannot tolerate gemcitabine plus capecitabine (1.8.7)" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/nasopharyngeal/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/bcg-and-intravesical-therapy/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/> ;
  onco:pathways <https://onco.cc/pathways/dna-replication-licensing/> ;
  onco:trials <https://onco.cc/trials/notable-trial/>, <https://onco.cc/trials/nct06828354/>, <https://onco.cc/trials/nct04442022/>, <https://onco.cc/trials/nct04384484/>, <https://onco.cc/trials/nct06435429/>, <https://onco.cc/trials/nct07491445/>, <https://onco.cc/trials/nct07805954/>, <https://onco.cc/trials/nct06508658/>, <https://onco.cc/trials/nct06459180/>, <https://onco.cc/trials/nct03800134/>, <https://onco.cc/trials/nct07621718/>, <https://onco.cc/trials/nct06976190/>, <https://onco.cc/trials/nct04969731/>, <https://onco.cc/trials/nct06312137/>, <https://onco.cc/trials/nct07604766/>, <https://onco.cc/trials/nct06118333/>, <https://onco.cc/trials/nct03164616/>, <https://onco.cc/trials/nct06619236/>, <https://onco.cc/trials/nct02486718/>, <https://onco.cc/trials/nct04974398/>, <https://onco.cc/trials/nct03178552/>, <https://onco.cc/trials/nct07564141/>, <https://onco.cc/trials/nct06445062/>, <https://onco.cc/trials/nct06710288/>, <https://onco.cc/trials/nct06601504/>, <https://onco.cc/trials/nct05482893/>, <https://onco.cc/trials/nct05775159/>, <https://onco.cc/trials/nct04083599/>, <https://onco.cc/trials/nct06646055/>, <https://onco.cc/trials/nct07049055/>, <https://onco.cc/trials/nct06219941/>, <https://onco.cc/trials/nct06922591/>, <https://onco.cc/trials/nct07124936/>, <https://onco.cc/trials/nct03775486/>, <https://onco.cc/trials/nct07255404/>, <https://onco.cc/trials/nct05431270/>, <https://onco.cc/trials/nct07483554/>, <https://onco.cc/trials/nct05669482/>, <https://onco.cc/trials/nct04657068/>, <https://onco.cc/trials/nct04844866/>, <https://onco.cc/trials/nct07563738/>, <https://onco.cc/trials/actuate-1801/>, <https://onco.cc/trials/nct07020221/>, <https://onco.cc/trials/nct07259590/>, <https://onco.cc/trials/nct06843447/>, <https://onco.cc/trials/nct04198766/>, <https://onco.cc/trials/nct07223047/>, <https://onco.cc/trials/nct06081959/>, <https://onco.cc/trials/nct05229497/>, <https://onco.cc/trials/nct07701486/>, <https://onco.cc/trials/nct06623422/>, <https://onco.cc/trials/nct06361888/>, <https://onco.cc/trials/nct05302284/>, <https://onco.cc/trials/nct06908304/>, <https://onco.cc/trials/nct06465563/>, <https://onco.cc/trials/nct03257033/>, <https://onco.cc/trials/nct06953999/>, <https://onco.cc/trials/nct05814354/>, <https://onco.cc/trials/nct07229586/>, <https://onco.cc/trials/nct03816163/>, <https://onco.cc/trials/nct03579836/>, <https://onco.cc/trials/nct07710885/>, <https://onco.cc/trials/nct05771480/>, <https://onco.cc/trials/nct05999994/>, <https://onco.cc/trials/nct06343948/>, <https://onco.cc/trials/nct07129993/>, <https://onco.cc/trials/nct03682068/>, <https://onco.cc/trials/nct07280377/>, <https://onco.cc/trials/nct04589234/>, <https://onco.cc/trials/nct07575191/>, <https://onco.cc/trials/nct06319820/>, <https://onco.cc/trials/nct06211764/>, <https://onco.cc/trials/nct06467357/>, <https://onco.cc/trials/nct06449222/>, <https://onco.cc/trials/nct07566156/>, <https://onco.cc/trials/nct05827796/>, <https://onco.cc/trials/nct03036098/>, <https://onco.cc/trials/nct02516241/>, <https://onco.cc/trials/nct05934331/>, <https://onco.cc/trials/nct07259317/>, <https://onco.cc/trials/nct05548296/>, <https://onco.cc/trials/nct02453282/>, <https://onco.cc/trials/nct06960577/>, <https://onco.cc/trials/nct06545955/>, <https://onco.cc/trials/nct05653453/>, <https://onco.cc/trials/nct07173751/>, <https://onco.cc/trials/nct06821503/>, <https://onco.cc/trials/nct07007559/>, <https://onco.cc/trials/nct04241185/>, <https://onco.cc/trials/nct06592326/>, <https://onco.cc/trials/nct02542293/>, <https://onco.cc/trials/nct03478488/>, <https://onco.cc/trials/nct04999969/>, <https://onco.cc/trials/nct06957886/>, <https://onco.cc/trials/nct06806033/>, <https://onco.cc/trials/nct06752811/>, <https://onco.cc/trials/nct03003962/>, <https://onco.cc/trials/nct03967977/>, <https://onco.cc/trials/nct07111546/>, <https://onco.cc/trials/nct05911295/>, <https://onco.cc/trials/nct06854445/>, <https://onco.cc/trials/nct06225596/>, <https://onco.cc/trials/nct04274426/>, <https://onco.cc/trials/nct04390399/>, <https://onco.cc/trials/nct07393542/>, <https://onco.cc/trials/nct06632951/>, <https://onco.cc/trials/nct07398339/>, <https://onco.cc/trials/nct06788912/>, <https://onco.cc/trials/nct06522737/>, <https://onco.cc/trials/nct07238283/>, <https://onco.cc/trials/nct06591520/>, <https://onco.cc/trials/nct06241781/>, <https://onco.cc/trials/nct02340117/>, <https://onco.cc/trials/nct06493552/>, <https://onco.cc/trials/nct07106762/>, <https://onco.cc/trials/nct07444541/>, <https://onco.cc/trials/nct04639986/>, <https://onco.cc/trials/nct05859750/>, <https://onco.cc/trials/nct07286266/>, <https://onco.cc/trials/nct06841354/>, <https://onco.cc/trials/nct07296341/>, <https://onco.cc/trials/nct06663137/>, <https://onco.cc/trials/nct06460298/>, <https://onco.cc/trials/nct01954992/>, <https://onco.cc/trials/nct05355298/>, <https://onco.cc/trials/prodige-4-accord-11/>, <https://onco.cc/trials/mpact/>, <https://onco.cc/trials/jaspac-01/>, <https://onco.cc/trials/apact/>, <https://onco.cc/trials/conko-005/>, <https://onco.cc/trials/conko-007/>, <https://onco.cc/trials/preopanc-2/>, <https://onco.cc/trials/scalop/>, <https://onco.cc/trials/panoptimox-prodige-35/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-burris-gemcitabine-pancreatic-jco-1997/> .